Biophotonics research expert Jarvis Lin was appointed CTO of Jellox Biotech in 2019, where he developed the world’s first and largest 3D pathology database to support precise cancer diagnosis, optimise patient treatment outcomes and match patients to the right drugs at the right time. He won the 2022 Intel RISE Technology Initiative (IRTI) award and several others from the Taiwanese government for technological and business innovation in 2021.